Bladder Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients must be =18 years old at diagnosis; 2.Histologically or cytologically-diagnosed MIBC or mUC between Jan 1 2020 to Dec 31 2021; 3.No prior treatment and received the first treatment during eligibility period in the corresponding selected site; 4. Patients must have informed consent form signed for the study or have conditions that are accepted by institutional review board/ independent ethics committee to waive ICF.
Exclusion criteria
Exclusion criteria: 1.Patients with multiple primary cancers as reported in EMR; 2.The patient has participated in any investigational program/interventional clinical trial with interventions outside of routine clinical practice for anti-tumor purpose.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Initial treatment patterns of MIBC and mUC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinicopathological feature of MIBC and mUC;Subsequent treatment patterns of MIBC and mUC; | — |
Countries
China
Contacts
Peking University First Hospital